Ailsa Dalgliesh ^Investor

Ailsa Dalgliesh is a Ph.D. trained professional with expertise in biomedical engineering and immuno-oncology. With a background in product and market knowledge, she has extensive experience in assessing early-stage technology and intellectual property. Ailsa has a proven track record of identifying and pursuing commercialization opportunities with Fortune 500 companies. Her achievements include publications in reputable journals and recognition from the National Science Foundation Graduate Research Fellowship Program. Ailsa's interests lie in the fields of cell and gene therapies, making her a valuable asset in the industry.